COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending marketing authorization and represents Moderna's fourth vaccine to receive a positive C ...

At Mishock Physical Therapy (MPT), we blend PT + DC-level musculoskeletal reasoning with an evidence-based treatment stack ...

The prevalence of waterpipe smoking (WPS) is increasingly recognised as a growing global public health concern. Available studies show that WPS exposes users to toxicants at levels similar to or ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

In a pragmatic cluster non-randomized trial, Alexandra Kulinkina and colleagues investigate the effectiveness of a clinical decision support algorithm ...

The U.S. Food and Drug Administration proposed on Monday a new framework to speed approvals of personalized treatments for ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline into key clinical stages in the U.S. and China. Concurrently, the c ...

In a study published in Nature and Science of Sleep in August 2025, 69 participants with poor sleep were offered a nightly dose of a magnesium compound. After four weeks, say the researchers, they ...

SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (Lynk Pharmaceuticals), a clinical-stage innovative drug development company focused on therapies for ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ...